Feb 9, 2018
BRIEF-Salix Provides Update On FDA Submission For Plenvu
Visit Now - http://zeroviral.com/brief-salix-provides-update-on-fda-submission-for-plenvu/
BRIEF-Salix Provides Update On FDA Submission For Plenvu
Feb 9 (Reuters) – Valeant Pharmaceuticals International Inc :
* SALIX PROVIDES UPDATE ON FDA SUBMISSION FOR PLENVU
* SALIX PHARMACEUTICALS- PDUFA ACTION DATE HAS BEEN EXTENDED TO ALLOW FDA MORE TIME TO REVIEW ADDITIONAL DATA THAT WAS RECENTLY PROVIDED AT ITS REQUEST
* SALIX PHARMACEUTICALS – FDA EXTENDED PDUFA ACTION DATE FOR REVIEW OF NDA FOR PLENVU (NER1006) BY THREE MONTHS TO MAY 13 Source text for Eikon: Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.